• Skip to main content

USA Mobile Drug Testing

  • Services
    • Drug Testing
    • Background Screening
    • Training and Support
    • Consumer Services
  • Customer Login
  • Blog
  • Drug Testing Locations
  • Contact

New Opioid Prevention Bill Introduced

Home / Drug News / New Opioid Prevention Bill Introduced

December 10, 2019 by David Bell

Last updated: January 30, 2023

Senator Robert F. Wicker (R-MS) introduced the Preventing Opioid and Drug Impairment in Transportation Act last week. It was just in time for it to make the Senate Committee on Commerce, Science, and Transportation’s Executive Session agenda. The Senate Committee meets on December 11th and will open discussion on the bill. It’s intended to strengthen existing opioid prevention tactics and focuses on collecting data in several different forms.

DATIA (Drug and Alcohol Testing Industry Association) will be monitoring the bill’s progress. So will many others in the safety-sensitive industry concerned with the continuing drug crisis our country faces.

The bill’s intent is to improve drug testing for transportation-related activities. If passed into law, it calls for implementing several different studies and reporting procedures. Ultimately, the goal is to increase the safety of everyone traveling throughout our nation by whichever means they choose.

Amtrak’s at the top of the list

The FMCSA Clearinghouse begins operation on January 6, 2020 requiring all employers of the trucking industry to submit queries on all potential new hires. The query searches specifically for drug or alcohol-related violations. Employers must also begin reporting all drug and alcohol violations incurred by current employees. The information is retained in the database until the violation has been remedied.

Once it’s up and running, this process will eliminate the possibility of drivers not reporting a violation to a new employer. Moreover, because it’s a national database, drivers can’t pick up and move to a new state to apply for a new CDL (Commercial Driver’s License) there.

If passed, the new bill requires Amtrak to submit controlled substance and alcohol testing records of all employees in like manner. Amtrak will establish an electronic database of test data to replace paper records. In addition, Amtrak must establish effective procedures to track and monitor drug and alcohol testing records that are maintained in the electronic database.

Lastly, Amtrak must submit a report to both the Committee on Commerce, Science, and Transportation of the Senate and the Committee on Transportation and Infrastructure of the House of Representatives. The report must describe the measures taken to improve compliance with the issue of employees self-reporting prescription drug use.

Changes in current regulations

Within a year after the Act is enacted, the Secretary of Transportation will determine if 49 CFR Part 240 and 49 CFR Part 242 should be revised to include requiring locomotive engineers or conductors to immediately report arrests due to drug or alcohol offenses. Personnel seeking certification to become an engineer or conductor must do the same.

If revisions will be made, the Secretary of Transportation will publish a notice in the Federal Register to that effect.

A safety-sensitive study

If the bill passes, the Secretary of State will be responsible for submitting a report to Congress that determines whether or not pipeline companies that operate from either Mexico or Canada into the United States perform drug testing of employees living outside the U.S. but who are responsible for maintaining and controlling pipeline within the U.S.  The drug tests must be comparable to those used for U.S. employees.

The report is to include information as to whether or not operators have sufficient testing procedures in place to ensure that pipelines within the U.S. are maintained safely.

Correcting an oversight

The bill calls for an amendment of 49 CRF Part 199 to improve the efficiency of drug testing for operators and pipeline contractors working for multiple operators in multiple states. The goal is to minimize duplicative audits of the same operators by the Pipeline and Hazardous Materials Safety Administration and other State agencies.

Drug use on the road

The NHTSA (National Highway Traffic Safety Administration) Administrator will conduct a study regarding ways to better detect impaired driving, which specifically includes marijuana and opioid-impaired driving. The study will last over a period of several years. The administrator will report updates regarding the study’s progress to Congress along the way.

Roadside oral fluid tests

The Secretary of Transportation will oversee a study. It will be in regard to the accuracy of onsite oral fluid drug testing for marijuana and opiates. The goal is to discover if their use will aid in reducing the potential impact on traffic safety.

The report will include:

  • The status of onsite oral fluid drug testing technology available
  • Information on the reliability and accuracy of the devices
  • Oral fluid research and pilot programs in the U.S. and other countries to assess how the technology is being utilized
  • State-based policies regarding implied consent and testing in impaired driving cases
  • Presenting instances for deploying this technology in the field
  • Discovering any legal and policy issues that could arise using this technology

DOT drug testing panel report

The bill requires the Comptroller General of the United States to review the DOT’s (Department of Transportation) process for setting guidelines and drug testing requirements for safety-sensitive employees subject to drug testing. The General will submit a report to both the Senate and House committees.

The report is to include:

  • A description of the HHS’s (Department of Human Health and Services) process for adding and removing drug categories included in Federal workplace drug testing requirements
  • An evaluation of the dependence of the DOT on the HHS’s determination whether or not to add new categories of drugs to the testing panel
  • An assessment of whether the HHS’s process for adding and removing drug categories from the Federal workplace drug testing requirements adequately addresses the needs of the industry to prevent drug and alcohol-related incidents

Will they add fentanyl?

In regard to opioid prevention, the Secretary of HHS must submit a status report pertaining to whether it will add fentanyl to the drug testing panel.

Hair testing guideline report

Lastly, the bill calls for the HHS Secretary to submit reports on the scientific and technical guidelines for hair testing. The report will detail the causes of the delay in submitting these guidelines to the Office of Management and Budget. The report is to include an estimated date by which the hair testing guidelines will be completed.

Further regulation regarding safety-sensitive employee drug testing is something the majority of, if not all, employers will embrace. Drug use is a huge safety hazard in the workplace and, certainly, on the road. Taking steps to kick it to the curb at every turn is a worthwhile endeavor indeed.

Filed Under: Drug News

Ready to learn more or schedule a drug test?

Service area:

USA
Canada

Find a drug testing location

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • District of Columbia
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Puerto Rico
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming

About David Bell

After seeing the damage caused by drug use first-hand, David sold his previous company and worked his way up through the ranks in the drug testing industry to help employers keep drugs and alcohol out of the workplace.

© USA Mobile Drug Testing

800-851-2021

11016 N Dale Mabry Hwy #204
Tampa, FL 33618


  • Headquarters Website
  • Franchise Information
  • Become an Affiiliate

Drug Testing Methods

  • Urine Drug Test
  • Mouth Swab Drug Test
  • Hair Drug Test
  • Blood Drug Test

Drug Testing Panels

  • 5 Panel Drug Test
  • 9 Panel Drug Test
  • 10 Panel Drug Test
  • 12 Panel Drug Test

Drug Testing Conditions

  • Pre-Employment Drug Testing
  • Random Drug Testing
  • DOT Drug Testing
  • Reasonable Suspicion Drug Testing
  • Post-Accident Drug Testing
  • Probation Drug Testing

Web design by Spartan Media

Do you need a drug test conducted at a certain date and time? Call us at and we will dispatch a mobile collection specialist to administer your drug tests at any location, 24 hours a day, 7 days a week.

x

Are you looking for more information about drug testing, a drug free workplace program, or compliance? Call us at and we'll be happy to answer any questions you may have and tailor a program to your specific needs.

x